LiviWell Inc. recently secured a major technological breakthrough with the issuance of U.S. Patent No. US12773356B2. This patent, titled ‘Vaginal fluid absorption and odor reduction’, introduces an absorptive device designed specifically to manage fluids and odor following intercourse. Inventors Michael Scott Ingber, Dan Seewald, and Julie Marie Moore developed a design that features a specialized shell, plunger, and a deployable absorptive unit.

NEW JERSEY PATENT OF THE MONTH – NOVEMBER 2026

The innovation focuses on a compact absorptive system that transitions from a compressed state within an applicator shell to an uncompressed state upon deployment. This mechanism effectively addresses a significant need in women’s intimate health by providing a discreet method to absorb discharge and maintain a balanced environment. Swanson Reed granted this invention the New Jersey Patent of the Month for November 2026 because it solves complex technical uncertainties in the development of targeted absorptive mechanisms.

Practical Applications and R&D Tax Credit Eligibility

The practical applications of this patent present strong opportunities for Research and Development tax credits in the United States. Companies developing innovative intimate health products often engage in iterative testing to overcome engineering challenges related to material absorbency, safe deployment mechanisms, and device comfort. The process of designing, prototyping, and validating the performance of deployable absorptive units requires dedicated experimentation. These activities directly align with the requirements of IRS Section 41 for qualified research. By documenting the systematic elimination of technical uncertainties in their design phases, manufacturers can leverage these experimental efforts to claim substantial R&D tax incentives.